Brief: VYNE Therapeutics Reports Year-End 2022 Financial Results

YARROW BIOSCIENCE

09/03/2023 21:03

March 9 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS REPORTS YEAR-END 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
    * VYNE THERAPEUTICS INC: QTRLY LOSS PER SHARE BASIC AND
DILUTED $
3.33

Source text for Eikon:  ID:nGNX6fGJLm 
Further company coverage:  VYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))